DASH vs ERNA
DoorDash, Inc. Class A Common Stock (DASH) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the DASH and ERNA stock pages for the full models.
Not investment advice.